Organon (OGN) Asset Utilization Ratio (2021 - 2026)

Organon (OGN) recorded quarterly Asset Utilization Ratio of 0.48 in Q1 2026, up 1.28% quarter-over-quarter from 0.47 in Q4 2025, and down 0.59% on a YoY basis from 0.48 in Q1 2025.

Organon (OGN) Asset Utilization Ratio (2021 - 2026) Analysis & Trends

Organon's Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.48 for Q1 2026.

  • In Q1 2026, Asset Utilization Ratio fell 0.59% year-over-year to 0.48; the TTM figure through Mar 2026 stood at 0.48 (down 0.59% YoY), while the FY2025 annual figure was 0.48, down 5.94% from the prior year.
  • Asset Utilization Ratio was 0.48 for Q1 2026 at Organon, up from 0.47 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.6 in Q2 2022 to a low of 0.47 in Q3 2025.
  • Historically, Asset Utilization Ratio has averaged 0.53 across 5 years, with a median of 0.53 in 2024.
  • The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio grew 5.29% in 2022, then dropped 10.72% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.58 in 2022, then declined by 5.94% to 0.54 in 2023, then retreated by 8.77% to 0.5 in 2024, then retreated by 5.0% to 0.47 in 2025, then climbed by 1.28% to 0.48 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.48 (Q1 2026), 0.47 (Q4 2025), and 0.47 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Gsk 92,134,969.93 Bn 92,134,964.97 Bn 7.76 Bn 0.53
2 Eli Lilly 1,027.45 Bn 1,022.17 Bn 16.22 Bn 0.63
3 Johnson & Johnson 559.08 Bn 537.03 Bn 15.96 Bn 0.48
4 AbbVie 394.75 Bn 385.40 Bn 10.78 Bn 0.46
5 Merck 295.12 Bn 289.47 Bn 12.09 Bn 0.50
6 Amgen 186.65 Bn 174.61 Bn 5.87 Bn 0.41
7 Gilead Sciences 159.22 Bn 151.50 Bn 5.52 Bn 0.52
8 Pfizer 146.00 Bn 133.23 Bn -1.21 Bn 0.12
9 Bristol Myers Squibb 113.22 Bn 102.77 Bn 8.07 Bn 0.55
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn 0.48

Historic Data

Download Data
DateValue
Mar 31, 2026 0.48
Dec 31, 2025 0.47
Sep 30, 2025 0.47
Jun 30, 2025 0.47
Mar 31, 2025 0.48
Dec 31, 2024 0.50
Sep 30, 2024 0.51
Jun 30, 2024 0.53
Mar 31, 2024 0.53
Dec 31, 2023 0.54
Sep 30, 2023 0.56
Jun 30, 2023 0.57
Mar 31, 2023 0.57
Dec 31, 2022 0.58
Sep 30, 2022 0.60
Jun 30, 2022 0.60
Mar 31, 2022 0.60
Dec 31, 2021 0.57
Sep 30, 2021 0.57
Jun 30, 2021 0.62